MyFinsight
Home
Blog
About
Net loss and other
comprehensive loss for the...
-$10,490K
(19.20%↑ Y/Y)
US
$1,301K
(-34.19%↓ Y/Y)
DE
$182K
(30.00%↑ Y/Y)
CA
$129K
(37.23%↑ Y/Y)
US
$444K
(-77.54%↓ Y/Y)
CA
$427K
(354.26%↑ Y/Y)
Net loss attributed
to shareholders...
-$9,540K
(39.22%↑ Y/Y)
Foreign currency
translation adjustment
-$950K
(-135.02%↓ Y/Y)
Net foreign
exchange (gain) loss
$1,245K
(157.43%↑ Y/Y)
Net finance income
$336K
(-2.04%↓ Y/Y)
Recurring Non Capital
$1,612K
Capital Equipment
$871K
Net loss before
income taxes
-$9,485K
(39.32%↑ Y/Y)
Total income tax
expense
$55K
(-14.06%↓ Y/Y)
Total other (income)
expenses
$1,581K
(186.63%↑ Y/Y)
Deferred tax recovery
-$13K
(7.14%↑ Y/Y)
Revenue (note 12)
$2,483K
(12.30%↑ Y/Y)
Operating loss
-$11,066K
(19.85%↑ Y/Y)
Income tax expense
$68K
(-12.82%↓ Y/Y)
Gross profit
$1,947K
(20.33%↑ Y/Y)
Cost of sales
$536K
(-9.61%↓ Y/Y)
Total operating
expenses
$13,013K
(-15.63%↓ Y/Y)
Selling, general and
administrative
$7,359K
(-21.09%↓ Y/Y)
Research and development
$5,654K
(-7.28%↓ Y/Y)
Back
Back
Income Statement
Profound Medical Corp. (PROF)
Profound Medical Corp. (PROF)
source: myfinsight.com